Assembly BillIntroducedCAN
A 4054: Requires retail licensees for on-premises consumption of alcohol and adult-use on-site consumption of cannabis licensees have opioid antagonists to be administered to patrons, staff or individuals on premises of such establishment.
What A 4054 does, verified January 8, 2026
The bill aims to require certain businesses where alcohol or cannabis is consumed to have opioid antagonists available. These opioid antagonists, such as naloxone or Narcan, are medications that can neutralize or negate the effects of opioids in the human body. The bill applies to retail licensees for on-premises consumption of alcohol and adult-use on-site consumption licensees for cannabis. The goal is to reduce the risk of opioid overdoses in these settings. The bill takes effect on the ninetieth day after it becomes a law.
Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to economic development (2026-01-07)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions2 total · showing 2
| Jan. 07, 2026 | referred to economic development |
| Jan. 31, 2025 | referred to economic development |
Latest bill textIntroduced version, January 31, 2025 · 336 words
STATE OF NEW YORK ________________________________________________________________________ 4054 2025-2026 Regular Sessions IN ASSEMBLY January 31, 2025 ___________ Introduced by M. of A. K. BROWN -- read once and referred to the Commit- tee on Economic Development AN ACT to amend the alcoholic beverage control law and the cannabis law, in relation to requiring certain businesses in which alcohol or canna- bis is consumed to have opioid antagonists The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 106 of the alcoholic beverage control law is 2 amended by adding a new subdivision 18 to read as follows: 3 18. All retail licensees for on-premises consumption shall contain an 4 opioid antagonist to be administered to patrons, staff or individuals on 5 premises of such establishment. For the purposes of this subdivision, 6 "opioid antagonist" means naloxone, narcan or any other medication 7 approved by the department of health and the federal food and drug 8 administration that, when administered, negates or neutralizes in whole 9 or in part the pharmacological effects of an opioid in the human body. 10 § 2. Section 77 of the cannabis law is amended by adding a new subdi- 11 vision 15 to read as follows: 12 15. Each adult-use on-site consumption licensee shall contain an 13 opioid antagonist to be administered to patrons, staff or individuals on 14 premises of such establishment. For the purposes of this subdivision, 15 "opioid antagonist" means naloxone, narcan or any other medication 16 approved by the department of health and the federal food and drug 17 administration that, when administered, negates or neutralizes in whole 18 or in part the pharmacological effects of an opioid in the human body. 19 § 3. This act shall take effect on the ninetieth day after it shall 20 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD06280-01-5
Text of A 4054 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions